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ABSTRACT 
The purpose of this study was to compare metabolic and performance 
effects of ingestion of glucose, acid-modified high amylose starch and placebo 
during endurance exercise at 60% of V02 peak. Specifically, we sought to 
determine effects on plasma glucose maintenance, total carbohydrate oxidation 
as measured by indirect calorimetry, exogenous carbohydrate oxidation using 
13C02 excretion, and endurance performance. Ten male subjects cycled to 
fatigue at 60% of V02peak, after ingesting acid-modified high amylose starch 
(AMS), glucose, or a sweet non-caloric placebo. The ingestion protocol consisted 
of a bolus feeding of 4 ml/kg (280 ml, 22 g CHO for a 70 kg person) at the onset 
of exercise, and 2 ml/kg body weight every 15 minutes for the duration of the 
exercise. All trials were separated by 1 week and treatments were administered 
in a random, double blind manner. The plasma glucose derived from exogenous 
carbohydrates (CHO) at the time of fatigue for AMS, and GLU were 23%, and 
46% respectively. A significant difference was seen among treatments. 
Maximum exogenous 13C oxidation rates were 0.69 g/min, 0.21 g/min for the 
GLU and AMS trials respectively. Exogenous carbohydrate oxidized was 
different among treatments. Overall time to exhaustion was significantly lower in 
the CON treatments (138 min), compared to the AMS (158 min) and GLU (159 
min) treatments. Carbohydrate in the form of an acid-modified starch was 
digested, absorbed, and metabolized when ingestion during endurance exercise, 
as supported by the direct measured of absorption and oxidation of the 
exogenous carbohydrate using 13C methodology. 
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INTRODUCTION 
Simple sugars such as glucose and sucrose are commonly used in nutritional 
products such as sports drinks and other nutritional supplements for weight loss and 
other medical applications. Ingestion of these products typically results in a large 
rise of both plasma glueose and insulin due to the rapid and complete digestion of 
the simple sugar. Such large glycemic and insulinemic effects may have a number 
of negative metabolic and health effects including enhanced lipid synthesis (41), 
impaired mineral absorption (24), and a relative hypoglycemia consequent to the 
insulin response (10). 
When ingested within one hour of starting exercise, simple sugars have been 
shown to cause plasma glucose concentration to drop below that of pre-exercise 
values and thus impair performance (10). These fin.dings have prompted 
researchers to search for more slowly absorbed carbohydrates that might still 
provide additional carbohydrate energy for the exercise without the negative effects 
associated with a high insulin concentration at the start of exercise. Starches 
containing a high amylose:amylopectin ratio are known to elicit a low glycemic 
response due in part to the slow rate of enzymatic hydrolysis of amylase chains 
compared to amylopectin (4). An alternative explanation for the low glycemic 
character of such starches is the relative indigestibility or "resistance" of these high 
amylase starches (4). 
Recent studies have provided evidence that acid modification of high amylase 
starch may increase the digestibility and thereby provide greater carbohydrate 
energy after ingestion ( 41 ). Despite the improved digestibility of the modified high 
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amylose starches, plasma glucose and insulin responses after ingestion remain low 
( 41 ). These observations suggest that modified high amylose starch could serve as 
an effective alternative carbohydrate and energy source in both liquid and solid 
nutritional supplements. Ingestion of acid-modified high amylose starch before 
exercise was previously shown to increase carbohydrate oxidation in a subsequent 
endurance exercise as indicated by calculations of fuel utilization from indirect 
calorimetry (29). However, there have been no studies to examine whether 
ingestion of these slowly digested starches during exercise could supply 
carbohydrate energy rapidly enough to provide metabolic and performance benefits 
in endurance exercise. 
Therefore the purpose of the present study is to compare metabolic and 
performance effects of ingestion of glucose, acid-modified high amylase starch 
(AMS), or a sweet non-caloric placebo drink during endurance exercise at 60% of 
V02 peak. Specifically, we sought to determine effects on plasma glucose 
maintenance, total carbohydrate oxidation as measured by indirect calorimetry, 
exogenous carbohydrate oxidation using 13C02 excretion, and endurance 
performance. 
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REVIEW OF LITERATURE 
Types of Carbohydrates and Their Structures 
The type of carbohydrate and its structure play significant roles in its 
contribution as a supplement for endurance exercise. Carbohydrates such as 
dextrose, fructose, lactose, sucrose, and glucose polymers of small molecular 
weight are often used in different liquid nutritional supplements for exercise (37). 
The small molecular weight of these carbohydrates may cause some undesirable 
gastrointestinal effects such as diarrhea and distention. Also, the osmotic pressure 
of these carbohydrates in the stomach and intestines can limit the availability of 
water for hydration purposes. Ingestion of these carbohydrates often causes a high 
insulin response in response to the glucose concentration in the blood. The acute 
response of high insulin concentrations can lead to hypoglycemia, and if exercising, 
to fatigue (37). 
Carbohydrates contribute 40-80% of total energy intake in human diets. Less 
than half of this intake tends to be from complex carbohydrate sources ( 41 ). 
Complex carbohydrates are often referred to as starches. A starch is a mixture of 
two polymers and is made by plants. The major components of starch are amylase 
and amylopectin. Both of these are high molecular weight molecules, with amylase 
having a linear structure and amylopectin a highly branched structure. In most 
starches, amylopectin comprises 70-80% of total starch and amylase 20-30% ( 41 ). 
An example of a starch containing 100% pure amylopectin includes waxy barleys 
and rice. The wrinkled pea contains high levels of amylase (>70%). 
4 
Reported benefits of complex dietary carbohydrates include normalizing blood 
insulin in humans (1 ). It was initially thought that all starches were digested similarly 
and more slowly than simple sugars, resulting in smaller increases in blood glucose 
after ingestion (2). Several studies have reported a wide range of glucose 
responses to different sources of starch ingested by normal individuals as well as 
individuals with impaired glucose tolerance. Therefore, Behall et al. 1983 (1) 
conducted a study to determine if consumption of a specific starch structure 
consumed as the predominate carbohydrate source would blunt the increase in 
postprandial glucose and insulin, which would be useful in reducing glycemic 
response in those who are carbohydrate sensitive. Glucose and insulin response 
curves indicated a significant change over time from fasting levels. The mean 
glucose levels after amylase at 30 min and 60 min were significantly lower and at 
180 min were significantly higher than the levels after amylopectin. Plasma insulin 
response after the starch feedings was also different Mean plasma insulin levels 
after the amylase feeding at 30 min, 60 min, and 120 min were significantly lower 
compared to levels after amylopectin ingestion. Plasma glucagons levels after the 
amylase at 30 min, 60 min, and 120 min were lower than those after the amylopectin 
meal. The glycemic index calculated by the methods of Jenkins et al. (25) was 
24.4% for the amylase cracker and 62.9% for the amylopectin cracker. 
Behal! et al. ( 1) also showed that consumption of the amylase meal after five 
weeks of high amylase ingestion resulted in reduced glucose and insulin response 
curves. It was noted that the decrease in glucose and insulin response after high 
carbohydrate diets couldn't be attributed completely to the higher levels of amylase 
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in the starch. Other factors may affect the glycemic response such as high fiber 
content, food source, cooking method, and particle size of the carbohydrate in the 
food. Behall et al. ( 1) concluded that the flattened insulin response observed in 
normal men may benefit hyperlipidemic subjects, as well as individuals who are 
carbohydrate sensitive, or who have diabetes. 
It has been suggested that starches with high amylase content yield more 
sustained plasma glucose levels and lower plasma insulin. Behall et al., 1988 (2), 
followed up their previous research with a study that would help clarify whether 
consumption of a specific starch structure as the predominant carbohydrate source 
would blunt the rise in postprandial glucose and insulin. Amylase, a straight chain 
starch has a molecular weight of -250, 000 while amylopectin has a molecular weight 
of -50 million because of its branching (2). 
These data indicated a significant reduction in glucose and insulin responses 
after consumption of amylase compared to amylopectin. Cornstarch containing 70% 
amylose and 30% amylopectin is the common type of amylose available 
commercially in food products. The amylose content, particle size, and cooking 
method may be the determining factors for most foods as to how fast the starch is 
digested and glucose appears in the blood. The total plasma glucose observed 
under the curves was alike; indicating that the two starches were digested to a 
similar extent, but that the rate at which glucose entered the blood was different. 
Goddard ( 19) was one of the first investigators who examined the specific 
component in starch responsible for differences in glucose and insulin responses 
(19). Goddard et al. (19) evaluated the effect of amylase and amylopectin content 
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on the glucose and insulin responses to rice. Thirty-three volunteers were given 
three types of rice containing 0, 14-17, or 23-25% of carbohydrates in the form of 
amylase. Blood glucose and insulin concentrations were measured every 30 
minutes for 180 minutes. At time 30 min, the glucose response to the high (23-25%) 
amylase rice was significantly lower than to the 0% amylase rice. At time 60 min 
there were no significant differences among the three amylase and glucose 
treatments. At time 120 min all three rice treatments elicited significantly higher 
plasma glucose responses than the glucose treatment. At time 30 min, the higher 
amylase containing rice treatment produced a lower insulin response than the other 
rice treatments. Peak insulin concentrations were measured at time 60 min. At time 
60 min, all rice varieties had a lower insulin response than the glucose, with the high 
amylase rice being the lowest. Investigators also noted that the insulin response 
curves declined more gradually with higher amylase content (19). Goddard (19) 
concluded that the data in this particular study indicated a significant difference in 
the glucose and insulin responses to rice with varying levels of amylase. A high 
level of amylase was associated with lower initial responses and slower declines in 
both glucose and insulin concentrations (19). These data suggest the presence of a 
factor in high-amylase rice that delays digestion and/or absorption of carbohydrate. 
It was concluded that the most likely explanation for the results obtained in the 
Goddard study ( 19) was related to differential enzymatic hydrolysis of amylase-rich 
rice and the presence of lipid-amylase complexes. 
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Digestibility and Glycemic Index of Different Starches 
The glycemic index (GI) provides a method of ranking foods rich in CHO 
according to the glucose response following their intake. Traditionally, foods 
containing carbohydrates have been classified as being "simple" (containing mono-, 
di-, and oligo-saccharides) or "complex" (containing polysaccharides or starches) 
(25).· 
The GI is a ranking of foods based on their actual postprandial blood 
glucose response compared to a reference food (7). 
GI = blood glucose area under the curve after test food 
X100 
blood glucose area after reference food 
The GI reflects the rate of digestion and absorption of a CHO-rich food. Many 
factors influence the digestion and absorption rates of CHO-rich foods (7). The form 
of food, including particle size and texture, along with the presence of soluble fibers 
may affect digestibility. Also, the degree of food processing and cooking may slow 
digestion. The presence of fructose or lactose both elicits a lower GI. The ratio of 
amylopectin to amylase alters the glycemic index. Bioactive nutrients such as 
phytates and lectins alter the glycemic index of a starch (7). 
Starch foods differ in the rates at which they are digested and at which they 
elicit blood glucose and insulin responses (34). This has been attributed to various 
factors, as mentioned earlier. In the studies previously mentioned by Behall (1, 2), it 
was noted that cooking methods might affect the glycemic response of these starch 
foods. Upon heating and cooling of high amylase starches, high levels of resistant 
8 
starches may form (5). Granfeldt, 1993 (20) found that-30% of the total starch in a 
high amylose com bread was enzyme resistant after cooking. Granfeldt, 1995 (21) 
investigated the importance of amylose:amylopectin ratio on the glucose and insulin 
responses to realistic com products. Two starches were used, one with -25% 
amylase and the other with 70-75% amylase (Amy 7). Both starches were c0oked 
and ingested in the form of Arepas (cornbread). Both starches were analyzed for 
potentially available starch. 
The investigators concluded that the meal of high amylase com Arepas 
produced significantly lower metabolic responses than did the com Arepas meal. 
Granfeldt et al. (21) concluded that the decreased metabolic response elicited by the 
high amylase com products seemed to be related to the lower digestion of amylase 
cornstarch. Therefore, the lower metabolic responses in the amylose starches were 
not affected by potentially available starch or cooking the starch. 
Amylose content may also affect the digestibility of a starch (2,3). Amylase 
has a linear structure, and starch granules rich in amylase are thought to have mo(e 
extensive hydrogen bonding and more crystalllinity in their structure than starch with 
little amylase (34). When these starches are cooked, they do not gelatinize as 
readily and therefore are digested more slowly and result in lower blood glucose and 
insulin responses than starches with low amylose content (34). Conflicting glycemic 
responses have been noted in response to rice digestion, and this may be due to 
differences in the varieties and cooking procedures of the rice (34). Panlasigui (33) 
investigated the rate of in vitro starch digestion and the in vivo blood glucose and 
insulin responses to the three varieties of long-grain, nonwaxy rice, all with similar 
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high-amylase content. They concluded that amylase content alone is not a good 
predictor of starch digestibility and glycemic response. Rice varieties with similar 
amylase contents can differ in physicochemical properties, which can influence how 
fast the starch is digested and the response of plasma glucose and insulin. 
O'Dea et al. (33) compared the glucose and insulin responses in six healthy 
young males to 75 g starch given as cooked white or brown rice which was either 
ground or unground. Their rationale behind the design of the study was to 
differentiate the effects of physical form and fiber content of starches and their 
affects on glucose and insulin responses (33). Blood glucose responses to the 
ground white and brown rice meals were significantly greater than the glucose 
responses to either unground rice meal throughout the first 90 minutes after 
ingestion. There were no differences between the ground white and ground brown 
rice meal. In the unground form, the brown rice elicited a lower glucose response 
than white rice for the first 120 min, but was not significantly different. The insulin 
responses followed the same trend as the glucose responses. O'Dea (33) did note 
that the peak insulin responses were twice as high in the ground rice as compared to 
the unground rice. The investigators concluded that any factors that slow down the 
digestion and absorption of carbohydrate and result in a lower insulin response is of 
potential benefit in the treatment of a wide range of disorders of carbohydrate 
metabolism including obesity, diabetes, and certain hyperlipidemias (33). 
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Modification of Starches 
Acid Modification 
Starches, in their natural form, are enclosed by granules, and difficult to 
digest. Without modification of the starch, it cannot be absorbed properly in the 
small intestine; hence it is resistant (30). Ma and Robyt (30} designed a means of 
modifying potato and waxy maize starches by means of hydrochloric acid in 
methanol, ethanol, 2-propanol, or 1-butanol. The process consisted of suspending 
the starch (25g} in 100 ml of methanol (0.05% water}, ethanol (0.01 % water), 2-
propanol (0.04% water), or butanol (0.1%water). The solution was heated to 65° 
and then 1 ml of hydrochloric acid was added to start the reaction, while continuing 
to heat the solution at 65°. The reaction ceased when 14 ml of M NaHC03 was 
added and then cooled in an ice bath. After fractionation, the starch was highly 
soluble in hot water up to a concentration of at least 20% (w/v). By using a modified 
corn starch (amylomaize-7) in this process, Ma and Robyt (30) found desirable 
benefits such as enhanced digestibility, slow release of metabolizable CHO, lower 
glucose and insulin responses, high oxidation characteristics, and low osmolarity of 
this acid modified amylomaize-7 starch (30). This modification could allow for an 
alternative to high glycemic index carbohydrate, without some of the disadvantages 
previously mentioned. 
Zhou et al. ( 41 ) used rats to study the effects of these modified starches 
compared to dextrose. The four experimental carbohydrates were commercial 
cornstarch (70% amylopectin), dextrose, modified water-soluble potato starch (70-
75% amylopectin} and modified water-soluble amylomaize-7 starch (70% amylase). 
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The water-soluble, modified potato starch had a lower digestibility (69%) than the 
commercial cornstarch, dextrose, or modified amylomaize-7 starch. The digestibility 
of amylomaize-7 starch was -90%. The other metabolic responses to amylomaize-7 
starch were close to those observed with commercial cornstarch or dextrose. Zhou 
concluded that the modified soluble amylomaize-7 starch may be useful in liquid 
nutritional supplements. 
Carbohydrate Ingestion Prior to Exercise 
Effect of High Glycemic Starch 
People typically participate in endurance activities within a few hours following 
a meal (11 ). Glucose ingestion will elevate plasma insulin, but if exercise is started 
when plasma insulin is high, the metabolic response to exercise includes a decline in 
blood glucose and plasma free fatty acids with a greater reliance on energy coming 
from muscle glycogen, when compared to exercise in a fasted state (10). Coyle et 
al., 1985 ( 11) conducted a study to compare the metabolic response of cyclists 
during moderate-intensity exercise in the fasted state with responses four hours after 
a high-carbohydrate meal. They examined blood glucose, insulin, and free fatty acid 
(FFA) concentrations, along with respiratory exchange ratios (RER), and muscle 
glycogen utilization. Seven endurance trained cyclists performed three trials, a 
familiarization trial, a fasted trial, and a fed trial, all one week apart. The fasted trial 
consisted of the cyclists exercising for 105 min at 70% of their predetermined V02 
max, following a 16 hour fast. The same exercise and sampling protocol was 
followed for the feeding trial, however subjects consumed a standard breakfast of 
-2.0 g/kg body weight of CHO and 0.3 g/kg body weight of protein four hours before 
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exercise. They (11) found that when exercise is begun 4 h after a high-carbohydrate 
meal, there is an increased reliance on carbohydrates and a decrease in blood-
borne substrates. This response occurs despite a return of blood glucose and 
plasma insulin to fasting levels throughout the first 60-100 min of prolonged 
moderately intense exercise. The preexercise meal did limit fat oxidation, yet did not 
limit glycogen availability during exercise. 
Effect of Low Glycemic Starch 
Thomas et al. (38) hypothesized that a low glycemic index food eaten prior to 
prolonged strenuous exercise may provide a slowly releasing source of blood 
glucose for the working muscles, which is not available after ingesting a high 
glycemic index food. Evidence has been conflicting concerning the fact that glucose 
consumed in the hour before prolonged strenuous exercise is unfavorable. Some 
studies have attributed this to the rapid rise in plasma insulin. It is possible that a 
low glycemic index food may provide the same advantages as glucose given 
intermittently during exercise. Therefore, Thomas et al. (38) decided to compare 
biochemical and physiological responses in trained athletes to a low glycemic index 
and high glycemic index food, ingested one hour before prolonged strenuous 
exercise. The investigators hypothesized that a low glycemic index food may have 
an advantage when eaten before prolonged strenuous exercise by providing a slow-
release source of glucose to the blood without an undesirable insulin surge. 
In the Thomas study, eight trained male cyclists performed four treatments in 
which one of four test foods was consumed one hour before cycling to exhaustion at 
65-70% V02max. The amount of CHO ingested was equal to 1 g of available CHO 
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per kg of body mass. The four meals were lentils, potato, glucose and water. 
Plasma glucose concentrations rose rapidly reaching a peak at 30-45 minutes 
followed by a sharp decline 15 min into the exercise to values lower than fasting, 
after potato and glucose ingestion. There was a gradual rise and fall in plasma 
glucose concentrations after lentil ingestion. Plasma insulin responses after potato 
and glucose rose rapidly but had a smaller rise after lentils. After 15 minutes into 
exercise, there were no differences among them. As far as performance, endurance 
time in the lentils trial was significantly longer than in the potato, glucose, and water 
treatments. The results from this study provide additional support for the hypothesis 
that foods with a low glycemic index have an advantage when eaten before 
prolonged strenuous exercise. This occurs by providing a slow-release source of 
glucose to the blood without an accompanying insulin surge. The low glycemic index 
meal of lentils prolonged endurance at a moderate intensity by 20 minutes compared 
to that of a high glycemic index food. In the later part of endurance exercise, higher 
concentrations of glucose and FFA were observed after consumption of low 
glycemic index foods compared to high glycemic index foods (37,38). Endurance 
time was longer following consumption of the low glycemic index food (38). 
Effect of High or Low Glycemic Starches 
DeMarco (14) compared postprandial glycemic, insulinemic, and physiologic 
responses to a low glycemic pre-exercise meal compared to one with a moderately 
high glycemic index. Ten trained cyclists consumed one of the test meals or water 
30 minutes before cycling 2 hours at 70% of predetermined V02max. The 
moderately high glycemic index meal consisted of cornflakes, banana, and milk. 
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The low glycemic index food consisted of bran flakes, apple, and unsweetened 
yogurt. The third meal, the control meal (CON), was water only. Plasma glucose 
levels were similar in all three trials 30 min post ingestion. Once exercise began, a 
sharp decline in plasma glucose concentrations in the high glycemic treatment and 
low glycemic index treatment was seen at min 20. By 120 min of exercise, plasma 
glucose concentrations for high glycemic index and CON had decreased significantly 
from 40 min of exercise, while plasma glucose concentrations in low glycemic index 
were well maintained. These trends were witnessed throughout the performance 
trial, and at exhaustion. After 60 min of exercise, no differences in insulin 
concentrations existed between the high glycemic index and low glycemic index 
treatments, yet both were still significantly higher compared to the CON trial. By 120 
min of exercise, all differences in plasma insulin concentrations among all three trials 
were eliminated. In terms of performance, time to exhaustion in the low glycemic 
index treatments (206.5 .± 43.5 s) was significantly longer than the high glycemic 
index treatments (129.5 .± 22.8 s) and the CON (120.0 .± 31.4s) trials. These results 
may support the use of low glycemic index meals for people participating in early 
morning competitive events (14). 
Guezennec et al. (22) conducted multiple experiments evaluating the level of 
oxidation between different carbohydrate foodstuffs when ingested one hour before 
exercise (22). The purpose of the study was three fold: 1) To determine whether 
complex CHO, such as rice, spaghetti, bread, or potatoes producing a wide range of 
blood glucose and insulin responses after oral ingestion, influenced the metabolic 
response to exercise, 2) To determine whether the difference in blood glucose and 
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insulin response after a spaghetti meal or glucose ingestion resulted in different 
levels of CHO oxidation during exercise and, 3) To investigate the influence of starch 
structure on the level of CHO oxidation during exercise. 
In experiment I, seven trained male subjects consumed one of five different 
carbohydrate foods: white bread, potatoes, polished white rice, white spaghetti, or 
glucose. A comparison was made between hormonal and metabolic response to 
spaghetti, bread, rice, potatoes, and glucose meals. Plasma glucose concentration 
rose significantly 30 min after all test meals. Rice and spaghetti elicited lower 
responses than other foodstuffs. No differences in glucose were observed between 
the glucose and potato meals. A decline in blood glucose was observed 60 min 
after all test meals at the onset of physical exercise_ After 30 min of exercise, blood 
glucose concentrations were significantly lower after ingesting glucose or the potato 
meal 1 hour before exercise, compared to the other diets. At the end of exercise the 
blood glucose concentration was still significantly lower in the glucose and potato 
meals (4.0 .:!: 0.1 mmol • 1-1) than after spaghetti and bread meals (4.7 .:!: 0.3 mmol • 
I -1 ). Sixty minutes after the ingestion of the foodstuffs, and at the onset of exercise, 
plasma insulin responses to glucose, potato, or bread did not differ and were higher 
than the values observed after spaghetti and rice meals. 
Experiment II of this study, examined two test meals, composed of either 13C 
naturally enriched glucose or spaghetti prepared with corn flour naturally rich in 13C. 
Nine trained male subjects ingested one of the two test meals one hour prior to 
starting exercise. Glucose levels were significantly higher after the glucose meal 
than after the spaghetti meal at time 30 min, and then decreased 30 min after the 
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onset of exercise. Plasma insulin response to the spaghetti was significantly lower 
compared to the glucose meal. A similar decrease in plasma insulin concentration 
was observed during exercise between the two treatments. When looking at 
carbohydrate oxidation, using the presence of 13C in expired air, during exercise at 
30 min, 60 min, and 90 min the values of 13C02 enrichment were significantly higher 
after the glucose meal than after the spaghetti meal. 
Experiment Ill was designed to measure the level of carbohydrate oxidation 
with different starch sources and different preparation methods. The starches 
consisted of either 100% amylopectin, 70% amylase: 30% amylopectin, 100% 
amylopectin, 70% amylopectin: 30% amylase, or glucose. Six trained subjects 
ingested each of the test meals, one week apart, 60 min prior to exercising for 120 
min. The gelatinized 100% amylopectin was oxidized at the same level as glucose, 
while the cooked amylase was oxidized more slowly. Crude amylase and crude 
amylopectin are poorly metabolized. The investigators concluded that there are 
differences in oxidation rates between carbohydrate foodstuffs ingested before 
exercise. The lowest oxidation level is associated with low blood insulin and glucose 
responses (22). 
Febbraio et al. (16) designed a study to determine whether preexercise CHO 
ingestion with different glycemic indexes affects exercise metabolism, such as 
muscle glycogen utilization, performance, and time to fatigue. Six endurance-trained 
men performed three exercise trials on a cycle ergometer after ingesting a high 
glycemic, low glycemic, or placebo (CON) meal 45 min prior to exercising at 70% 
V02 peak for 120 min. Upon completion of 120 min of cycling, subjects performed a 
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15-min performance ride where total work (kJ) was measured. Ingestion of the high 
glycemic index meal before exercise resulted in a significantly higher blood glucose 
concentration at time 15 min, compared to the low glycemic index and CON 
treatments. No differences were seen in blood glucose among the treatments after 
the 15 min mark of exercise. Plasma insulin concentration was higher in the high 
glycemic index feeding throughout all of exercise. Also, plasma FFA concentration 
remained lower throughout exercise in the high glycemic index treatments compared 
to low glycemic index and CON. 
Despite these results, no differences in the rate of muscle glycogen utilization 
or exercise performance were observed among the three trials. These findings are 
in contrast to those of Thomas et al. (38) mentioned earlier, who found that an 
increase in exercise performance was found after the ingestion of a low glycemic 
index food. In the Febbraio (16) study, glycogen, lactate, and plasma glucose 
concentrations were all similar at the end of the performance ride amongst the three 
trials. They were not surprised about the lack of differences in performance, since 
the limit to performance during this type of exercise is often related to muscle 
glycogen depletion or lactate accumulation (17). 
Carbohydrate Ingestion During Endurance Exercise 
Several studies have been conducted evaluating the effect of carbohydrate 
ingestion during endurance exercise. CHO ingestion provides a means of rapidly 
altering CHO availability during exercise (9). In a review article, presented by 
Coggan and Coyle (9), the effects of CHO ingestion during prolonged exercise on 
metabolism and performance were evaluated. During moderate intensity exercise 
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(50-75% V02max) CHO ingestion has little effect on insulin concentrations 
compared to those observed in the fasted state. The increases in plasma FFA and 
glycerol concentrations during exercise were blunted. These small changes in 
insulin and changes in FFA and glycerol concentrations suggest that the rate of fat 
oxidation is not greatly affected by CHO ingestion during moderate intensity exercise 
(9). At the time, there was no direct method of measuring blood glucose utilization in 
respect to CHO feedings during exercise. In the absence of direct data, Coyle (12) 
estimated CHO oxidation by measuring muscle glycogen utilization in subjects fed 
CHO throughout moderate intensity exercise. Any additional CHO oxidized was 
assumed to represent blood glucose (12). Coyle, 1986 (12) estimated carbohydrate 
oxidation reaching -1.0 g/min after - 2 hours of exercise. Coggan and Coyle, 1989 
(8) investigated metabolism and performance following carbohydrate ingestion late 
in exercise. Their goal was to determine whether a single carbohydrate feeding 
could rapidly restore and maintain plasma glucose availability late in exercise. Six 
well-trained male cyclists participated in the study. Each subject completed two 
experimental exercise trials, 1-3 weeks apart, which consisted of exercise to fatigue 
at an intensity just below the individuals' blood lactate threshold. The trials 
consisted of ingesting 3 g of carbohydrate per kg of body weight after 135 min of 
exercise, or a lemon flavored placebo drink of the same volume. 
Coggan and Coyle (8) concluded that a single concentrated carbohydrate 
feeding after 135 min of cycling at 70% of V02 max could restore and maintain 
plasma glucose during continued exercise. No changes were witnessed in plasma 
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FFA or plasma insulin concentrations. This maintenance of blood glucose and 
increase in respiratory exchange ratio helped delay time to fatigue by -30 min. 
Burke et al. (7) studied the effects of the glycemic index of preexercise meals 
on metabolism and performance when CHO was ingested throughout exercise. Six 
endurance trained cyclists performed three treatments of 2-h of cycling at 
approximately 70% V02 max, followed by a performance ride of 300 kJ. The meals 
consumed 2 hours before exercise consisted of 2 g CHO/kg body mass of either 
high glycemic index potato or low glycemic index pasta, or a low-energy jelly. 
Immediately prior to and during exercise subjects ingested a 1Og/100 ml glucose 
solution, which equaled 24 ml/kg body mass. Total CHO oxidation for the high 
glycemic index, low glycemic index, and control treatments were similar. Differences 
were found in preexercise glucose, insulin, and free fatty acids among treatments. 
There was no difference in time to completion for the performance ride. The 
investigators concluded that preexercise CHO intake has little effect on metabolism 
or on subsequent performance during prolonged cycling. 
El-Sayed (15) had subjects ingest an 8% glucose solution (CHO) or placebo 
solution at rest, during, and immediately after submaximal exercise. Nine male 
cyclists performed two separate trials at 70% V02max for 60 min, followed by a 1 O 
min performance ride. Glucose concentrations at rest following the ingestion of 
CHO were significantly higher compared to placebo. At 30 and 60 min during 
submaximal exercise, plasma glucose concentrations decreased significantly in the 
CHO trial compared to the placebo trial. Following the performance ride, glucose 
levels increased significantly in the CHO trial. No change in FFA was detected 
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among treatments during the trials. A significantly greater workload was achieved in 
the CHO trial performance ride compared to the placebo trial. These results suggest 
that the ingestion of an 8% glucose solution before and during submaximal exercise 
significantly increased subsequent maximal performance capacity in trained rides. 
Moodley et al. (31) studied the rates of exogenous CHO oxidation during 90 
minutes of cycling in trained cyclists at a moderate intensity (70% V02 max). 
Subjects ingested glucose, sucrose, or glucose polymer solutions at concentrations 
of 7.5%, 10%, or 15%. Total CHO oxidation was not influenced by CHO type or 
concentration. Gastric emptying and rate of exogenous CHO oxidation was greatest 
for the glucose polymer solutions. The investigators concluded that factors other 
than gastric emptying limit the rate of exogenous CHO oxidation from solutions 
ingested during exercise. 
Jeukendrup et al. (27) conducted a study to investigate whether glucose 
ingestion during prolonged exercise reduces whole body muscle oxidation, to 
determine the extent to which glucose leaving the plasma is oxidized during exercise 
with and without carbohydrate ingestion, and to obtain an approximation of 
gluconeogenesis. Six-well trained cyclists exercised for 120 min on a bicycle 
ergometer at 50% V02max. Three trials consisted of water, a 4% glucose solution, 
or a 22% glucose solution. The rate of appearance of glucose, muscle glycogen 
oxidation, glucose carbon recycling, metabolic clearance rate, and non-oxidative 
disposal of glucose were measured with dual tracer infusion of [U-13C]-glucose and 
[6,6-2H2] glucose. Breath samples were collected and analyzed for 13C/12C ratio. 
Blood samples were taken and analyzed for glucose, lactate, free fatty acids, 
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glycerol, insulin, and 13C/12C ratios of plasma glucose. The rate of appearance of 
glucose was higher with ingestion of a high glucose solution. Carbohydrate 
oxidation during the last half hour was 130 .± 11 mM kg -1 min-1 in the fasting 
treatment, 156 .± 10 mM kg - 1 min-1 during the low glucose treatment, and 179 .± 6 
mM kg-1 min-1 in the high glucose treatment. 
The researchers concluded that muscle glycogen oxidation during exercise 
was not reduced by glucose ingestion. Their findings were in agreement with 
several direct measurements of muscle glycogen concentrations in muscle biopsies 
before and after cycling with or without carbohydrate supplementation. 
Summary 
Starches with varying glycemic indexes have different responses when 
ingested at rest, before exercise, or duri~g exercise. Starches with a higher ratio of 
amylase to amylopectin will a lower glycemic response (Figure 1 ). Ingestion of a low 
glycemic starch prior to exercise may provide a slowly releasing source of blood 
glucose to working muscles, and in some cases may also prolong time to fatigue 
(37). High glycemic starches are oxidized faster, and provide glucose at a faster 
rate than a low glycemic starch (22). Thus the modification of a high amylase starch 
into a more slowly absorbed carbohydrate may still provide additional carbohydrate 
energy for exercise, without the negative effects associated with a high glycemic 
index starch. 
...--... 
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Figure 1. Glycemic index of modified starches, dextrose, and 





Ten endurance-trained male cydists were recruited from a local cycling team 
(Table 1 ). All subjects were informed about the testing procedures and the risks of 
participating in this study. All subjects read and signed an informed consent form 
before participating in this study. All aspects of the study were reviewed and 
approved by the Iowa State Human Subjects in Research Committee prior to starting 
the study. 
Preliminary Testing 
The training status of the cydists was determined from training logs and peak 
oxygen uptake (V02 peak) testing. Subjects reported to the laboratory for 
measurement of V02 peak using a graded exercise test on a Lode Excalibur 
electronically braked cyde ergometer. The graded exercise test consisted of cyding 
at 50 watts at a comfortable pedal rate. The workload was increased every 3 
minutes by 50 watts until voluntary exhaustion, defined as the inability to maintain a 
pedal rate greater than 50 rpm. Expired gases were collected in a mixing chamber 
and continuously analyzed for oxygen (Applied Electrochemistry SA-3 0 2) and 
carbon dioxide (Ametek CD-4 C02 analyzer) fractions. Gas analyzers were 
calibrated with a known standard prior to each exercise trial. These data were used 
to calculate oxygen consumption (V02) and respiratory exchange ratio. 
Exercise Protocol 
Approximately 36-40 h prior to each experimental trial, all participants were 
required to do a depletion exercise for 2 h at 60% V02 peak in order to minimize the 
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possible contribution of endogenous 13C. For the experimental treatments, subjects 
reported to the lab after an overnight fast Their body mass was recorded and a 
flexible catheter was inserted into a forearm vein for blood sampling. The exercise 
protocol consisted on cycling at a workload previously determined to elicit 60% V02 
peak on the Load Excalibur ergometer. The exercise was performed to exhaustion 
(-2-3 hrs), defined as the time when the subject reported he could no longer 
maintain the prescribed workload. No verbal encouragement was given to the 
subjects, but they were instructed to complete as much work as possible. Each 
subject received all treatments. All trials were performed in a random, double blind 
manner, and were separated by one week. 
Exercise Feedings 
The experimental exercise tests consisted of three separate conditions, 1 ) 
ingestion of a thin-boiled amylomaize-7 starch suspended at 8% (H20) 
concentration, 2) ingestion of glucose dissolved at 8% (H20), and 3) ingestion of a 
sweet non-caloric placebo. The ingestion protocol consisted of a bolus feeding of 4 
ml/kg (280 ml, 22 g CHO for a 70 kg person) at the onset of exercise, and 2ml/kg 
body weight every 15 minutes for the duration of the exercise. This particular dosing 
protocol was chosen based on previous research showing increased plasma 13C 
enrichment and increased 13C02 enrichment during the second hour of exercise 
when glucose is consumed according to this schedule (40). 
Physiological and Metabolic Measurements 
Throughout the duration of exercise, blood and respiratory gas samples were 
obtained at 30-minute intervals. Respiratory gases were collected in a 3 L mixing 
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chamber and continuously sampled for 02 and C02 concentrations for the calculation 
of V02, VC02, and respiratory exchange ratio. Vacutainer tubes were filled directly 
from the mixing chamber in duplicate to determine 13C/12C in the expired C02. A 10-
ml blood sample was drawn prior to the pre-exercise feeding and every 30 minutes 
throughout the exercise for metabolite measurements. All blood samples were 
transferred to a vacutainer tube and stored in ice until they could be centrifuged 
immediately after the exercise was completed. The separated plasma was later 
analyzed for concentrations glucose (Sigma Chemical HK-60 kit), insulin 
concentrations (Diagnostic Products, Inc, Coat-A-Count Insulin kit), and free fatty 
acids (Waka NEFA-C kits) and 13C enrichment in glucose. 
Dietary and Exercise Control 
Subjects were instructed to keep a food diary two days prior to the first trial 
and to repeat this food intake prior to the remaining two treatments. Diets were 
analyzed using Nutritionist 5.0 computer software for kilocalories, percentage 
carbohydrate, percentage fat, and percentage protein. Subjects were also instructed 
to refrain from 13C enriched foods, which includes foods containing or made from 
com products. Subjects were instructed to maintain normal training status 
throughout the study. 
Calculations and Design Analysis 
Percent glucose derived from exogenous CHO was measured through a 13C-
Combustion analyses performed via Dumas combustion on a Europa ANCA-:-NT 
system and subsequent isotope analysis on a Europa 20/20 Stable Isotope Ratio 
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Analyzer. The breath 13C02 analyses were performed on either a Europa 20/20 
Stable Isotope Ratio Analyzer or a Finnigan BreathMat Isotope Ratio Analyzer. 
Total CHO oxidation rate was calculated from V02 and RER using standard 
equations originally designed by Mosora (32) and later modified by Peronnet (35) to 
correct for background 13C. Exogenous CHO oxidation was calculated from the 
measurement of VC02 and 13C/12C in expired C02 as described by Peronnet (35). 
Absorption of exogenous glucose was confirmed by calculation of percent of plasma 
glucose concentration derived from exogenous CHO using the method of 
Jeukendrup (26). 
The 13C enrichment of expired air was expressed as the 8 per mil difference 
between 13C/12C of the sample and a known laboratory reference standard 
according to the formula 
o13C (per mil)= [(13C/12C sample) I (1 3C/12C standard)-1] 
x 103 (1 3C/12C standard= 0.112372) 
Exogenous carbohydrate oxidation (EXO) was calculated from measurements of 
VC02 and 13C02 enrichment of expired air according to the equation proposed by 
Perronett (35): 
EXO (g/min) =VC02 x (Rbkg- Rexp) I (Rb1<g- Ring) -1/tc 
The cS 13C was related to an international standard (PDB standard = 1.12372). 
Two-way (time and treatment) analysis of variance (ANOVA) with repeated 
measures was used to detect significant mean differences among and between 
treatments. Three levels of treatment (placebo, AMS, glucose) were used as the 
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first factor and time was used as the second factor. Level of significance was set at 





V02 was not significantly different among the three treatments. V02 did 
increase from time 30 to the end of exercise in each treatment, with the end of 
exercise being significantly higher than the beginning of exercise (Table 2). A main 
effect for treatments was seen when measuring respiratory exchange ratios (RER) 
(p< 0.03). An interaction effect was seen (p < 0.04), with glucose being higher than 
placebo, and AMS producing RERs equal to that of the glucose treatments. AMS 
and glucose were higher than placebo, mainly in the second hour of exercise (Table 
2). 
Total Carbohydrate Oxidation 
A main effect for trial (p<.01) was found when analyzing total carbohydrate 
oxidation. Carbohydrate oxidation decreased over time, starting at just over 2.0 
g/min in all 3 treatments. No significant differences where found between the AMS 
and glucose treatments. Also, no significant differences between the AMS starch 
and placebo treatments were observed at any time point, though carbohydrate 
oxidation appeared slightly elevated in the AMS treatment compared to the placebo 
treatment. 
Total Fat Oxidation 
A main effect for trial (p < .0001) was found when analyzing total fat oxidation. 
·Total fat oxidation was steady over time in the glucose and AMS trials. Total fat 
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oxidation increased during the second hour in the placebo treatment. Total fat 
oxidation was significantly higher during the placebo treatments at time 90 and 120 
compared to the glucose and AMS treatments. 
Plasma Glucose Concentration 
Differences in plasma glucose concentration were seen between the AMS 
and glucose treatments in the last hour of exercise, with plasma glucose 
concentrations being higher in the glucose and AMS treatments compared to the 
placebo treatments. There was a significant (p < 0.05) difference among treatments 
in the plasma glucose concentration during exercise (Figure 2). An interaction 
existed among the treatments in the last hour of exercise (p < 0.0001) (Figure 2). 
Peak plasma glucose means for the placebo, AMS, and glucose treatments were 
5.40 mM, 5.20 mM, and 6.20 mM, respectively. Plasma glucose was significantly 
lowered at the end of exercise in the placebo and AMS treatments compared to the 
start of exercise, but not in the glucose treatments. 
Plasma Insulin Concentrations 
Insulin concentration was similar before exercise in the three treatments. 
Ingestion of glucose at the onset of exercise and at 15-minute intervals resulted in 
increased insulin concentration that persisted throughout the exercise. In both the 
placebo and AMS trials, insulin concentration declined during exercise with no 
differences between these two trials. A main effect for treatments (p < .01) was 
observed in plasma insulin concentrations during exercise (Figure 3). No significant 
differences were seen in insulin concentrations between the AMS and glucose 
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treatments at any time point. Mean insulin concentration for the placebo, AMS, and 
glucose treatments were 3.35 µIU/ml, 4.04 µIU/mt, and 5.71 µIU/ml, respectively. 
Plasma FFA Concentration 
In all three trials free fatty acid (FFA) concentration rose during exercise. 
Plasma FFA concentrations were different among treatments (Figure 4). The 
glucose trial yielded the lowest FFA concentrations among all treatments, and was 
significantly lower at the end of exercise in the glucose treatments compared to the 
placebo and AMS treatments. An interaction effect (p < 0.001) was seen among 
treatments. Mean FFA concentrations were higher in the placebo trial (0.77 mM) 
. compared to the glucose trial (0.52 mM), but no differences were seen between the 
AMS (0.67mM) and placebo treatments (Figure 4). 
Plasma Glycerol Concentration 
Similar to the response of FFA concentration, plasma glycerol concentration 
increased steadily throughout exercise in all three treatments. However, the glycerol 
concentration response was less with the glucose feeding than with either placebo 
or AMS. There was no difference in the glycerol concentration response between 
AMS and placebo (Figure 5). An interaction among treatments (p < 0.001) was 
seen. Plasma glycerol concentrations were significantly lower during the last two 
hours of exercise in the glucose treatment. Glycerol concentrations at time zero for 
the placebo (0.24 mM), AMS (0.21 mM), and glucose (0.20 mM) were significantly 
lower than at the end of exercise (1.10mM, 0.99 mM, 0.64 mM). 
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13 C Labeling 
A significant difference among treatments was seen with respect to percent 
glucose derived from exogenous carbohydrate (p < .01) (Figure 6). Mean glucose 
values at the end of exercise for the AMS, and glucose treatments were 25.0%, and 
46.0% respectively. Percent glucose derived prom exogenous CHO in the glucose 
treatment, was significantly higher at all time points during exercise among the 
treatments. 
Exogenous carbohydrate oxidized (g/min) was different among treatments (p 
< .0001 ). The glucose trial was significantly higher than the AMS at all time points, 
with a maximum exogenous CHO oxidation occurring at the end of exercise (0.69 
g/min, 0.21 g/min) (Figure 7). 
Performance Measurements 
Rating of perceived exertion (RPE) did not differ among the treatments (Table 
3). Fullness was different among treatments (p<0.0002). Fullness was significantly 
higher in the AMS treatments compared to the placebo and glucose treatments 
(Table 3). 
Overall time to exhaustion in the AMS and glucose treatments were not 
different from each other. Overall time to exhaustion was significantly lower in the 
placebo (138 min), compared to the AMS (158 min), or glucose (159 min) treatments 
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Figure 2. Plasma glucose concentration (mean ±_SEM) during 60% V02 peak 
exercise after ingestion of placebo, acid modified starch (AMS), or glucose. Main 
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Figure 3. Plasma insulin concentration (mean .± SEM) during 60% V02 peak 
exercise after ingestion of placebo, acid modified starch (AMS), or glucose feedings. 
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Figure 4. Plasma FFA concentration (mean.:!: SEM) during 60% V02 peak exercise 
after ingestion of placebo, acid modified starch (AMS), or glucose feedings. Main 
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Figure 5. Plasma glycercol concentration (mean .±. SEM) during 60% V02 peak 
exercise after ingestion of placebo, acid modified starch (AMS), or glucose feedings. 
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Figure 6. Plasma glucose (mean ± SEM) derived from exogenous carbohydrates 
during 60% V02 peak exercise after ingestion of placebo, acid modified starch 
(AMS), or glucose feedings. Main effect for trial (p < 0.0001, Glucose > AMS 
>Placebo). Trial x time interaction ( p < 0.0001). 
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Figure 7. Exogenous carbohydrate oxidation (mean.:!: SEM) after background 
subtraction during 60% V02 peak exercise after ingestion of acid modified starch 
(AMS) or glucose feedings. Main effect for trial (p < 0.0001, Glucose > AMS). Trial 
x time interaction (p < 0.0001). 
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·Figure 8. Time to fatigue during 60% V02 peak exercise after ingestion of 
placebo, acid modified starch, or glucose feedings. Means .± SEM. AMS= 
Glucose > Placebo. Main effect for trial ( p < 0.11) 
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Table 3. Rating of perceived exertion (RPE) and fullness index (mean± SEM) 
30 60 90 120 End of Exercise 
RPE 
Placebo 12.0 .± 0.0 13.0 .± 0.0 15.0 .± 1.0 16.0 .± 0.0 17.0 + 0.0 
AMS 12.0 .± 0.0 13.0 .! 0.0 14.0 .! 1.0 15.0 .! 1.0 17.0 + 0.0 
Glucose 12.0 .± 0.0 13.0 :!:. 0.0 14.0 :!:. 1.0 16.0 :!:. 1.0 17.0 + 1.0 
FULLNESS 
Placebo 2.0.:tO.O 2.0 .! 0.0 2.0 .! 0.0 2.0 .! 1.0 2.0 + 1.0 
*AMS 3.0±.0.0 3.0 :!:. 1.0 3.0 :!:. 1.0 4.0 .! 1.0 4.0 + 1.0 
Glucose 2.0 .± 0.0 1.0 ±.0.0 1.0±. 0.0 1.0 ±.0.0 1.0 + 0.0 
-* Indicates main effect for AMS 
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DISCUSSION 
Because glucose is a rapidly absorbed CHO, ingestion at rest causes a large 
rise in plasma glucose concentration and a resultant increase in insulin 
concentration (10). When ingested during submaximal exercise, when tissue uptake 
of glucose is accelerated, glucose does not cause a large insulin response (9). 
Accordingly, glucose ingestion during exercise helps to prevent the drop in plasma 
glucose concentration, the decline in CHO oxidation, and delays fatigue by providing 
an additional source of CHO, especially in the later parts of exercise. Coggan (8) 
showed that ingestion of a single feeding of glucose polymers, late in exercise, 
maintained plasma glucose concentration and CHO oxidation through 3 hours of 
endurance exercise (8). This strategy improved performance by an average of 21% 
or 36 minutes (8). Subsequent studies have confirmed the benefit of glucose 
ingestion during exercise and have suggested a maximal oxidation rate of 
exogenous glucose at up to 1.0 g/min (12). This was estimated by measuring 
muscle glycogen utilization; any additional CHO oxidized was assumed to represent 
blood glucose. This method did not take into account background subtraction of 
CHO oxidation, and most likely overestimated the maximal oxidation rate of 
exogenous glucose. 
In the present study, glucose ingestion during exercise had similar metabolic 
and performance effects as shown in previous studies. The decline in plasma 
glucose concentration in the second hour of exercise was prevented, CHO oxidation 
was maintained at a higher level than placebo, and endurance was improved 
compared to the placebo feeding. Measurement of exogenous CHO using 13C02 
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excretion confirmed a relatively high rate of glucose oxidation at approximately 0.69 
g/min. These results agree with studies done by Peronnet (36), who found glucose 
oxidation to be an average of 0.60 g/min, when correcting for background 13C (36). 
High plasma insulin concentrations, in response to elevations in plasma 
glucose, have been shown to decrease the level of plasma FFA and glycerol 
concentrations during exercise (13), due to the anti-lipolytic effect of insulin. The 
glucose feedings yielded the lowest FFA concentration among all treatments, and 
was significantly lower at the end of exercise in the glucose treatments compared to 
the placebo treatment. The same trend was seen with the plasma glycerol 
concentrations. 
It has been hypothesized that a low glycemic index meal given prior to 
endurance exercise may be just as advantageous as glucose given intermittently 
during exercise. Thomas, 1991 (38) compared biochemical and physiological 
responses in athletes to a low glycemic index and high glycemic index food ingested 
one hour before exercise. The rationale behind their study was that the low 
glycemic index food would provide a slow-release source of glucose to the blood 
without an undesirable insulin surge. In the later part of exercise, where glucose 
maintenance is most important, higher levels of glucose and FFA were observed 
after consumption of low glycemic index foods compared to high glycemic index 
foods. Endurance time was also longer in the low glycemic index food trial, and as 
mentioned above, no difference was seen between the high glycemic index and 
placebo treatments in terms of performance. Similar results were obtained by 
DeMarco, (14) who also observed improved maintenance of plasma glucose 
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concentrations in the later part of exercise and longer time to exhaustion with 
ingestion of a low glycemic index meal before exercise, compared to a high glycemic 
index or placebo trial. 
Rather than providing a low glycemic index mixed meal as a pre-exercise 
feeding, an earlier study in this lab (37) tested the possible metabolic effects of pre-
exercise ingestion of an acid-modified high amylase starch. In that study, they 
concluded that when ingested before exercise, AMS appeared to be slowly 
absorbed and oxidized for energy during endurance performance. This conclusion 
was based on the finding that modified starch fed in that trial elicited a lower 
glycemic response than pre-exercise glucose ingestion. The modified starch 
resulted in a small, but continued elevation of plasma glucose throughout exercise, 
indicating improved availability in the later stages of exercise. Furthermore, that 
study also observed an increase in total carbohydrate oxidation during the exercise 
that was equivalent to the increase that occurred with the glucose feeding. The 
current study used these same measurements, along with direct measurements of 
oxidation through the appearance of 13C in plasma and extracted from expired air. 
Measurement of exogenous CHO oxidation using 13C02 extraction allows a direct 
means of estimating CHO oxidation. Percent glucose derived from exogenous 
CHO, using this technique, was higher than placebo at the start of exercise and 
remained steady throughout the duration of exercise. The same trend was 
witnessed in the measurement of exogenous CHO oxidation (g/min). These two 
measurements together, directly indicate that AMS is digestible and available for 
energy during exercise. 
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No studies have attempted to assess the effect of low glycemic CHO ingested 
during exercise· on metabolic responses or endurance. The relatively slower 
absorption of low glycemic index CHO may not provide plasma glucose at a fast 
enough rate to prevent the plasma glucose decline and the associated drop in CHO 
oxidation. In general, high-amylose starch is thought to be less digestible than 
amylopectin (41). As mentioned previously, an alternative explanation for the low 
glycemic character of starch is the relative indigestibility or "resistance" ofthese high 
amylase starches (4). Therefore, either a slower rate of digestion (delivery of 
exogenous glucose to the circulation) or indigestibility of the AMS may preclude this 
starch from contributing to the maintenance of plasma glucose and carbohydrate 
oxidation when ingested intermittently during exercise. 
In the present study, total carbohydrate oxidation was maintained equally well 
with both glucose feeding and AMS feeding when compared to placebo. Plasma 
glucose concentrations (mM) were different between the glucose and AMS 
treatments, with glucose feedings providing higher plasma glucose concentrations in 
the later parts of exercise. However, plasma glucose concentrations in the AMS 
treatments were significantly higher than the placebo treatment, indicating that the 
AMS was providing much needed CHO in the later stages of endurance exercise, 
but not at the same rate as glucose. 
As expected from the higher plasma glucose concentrations in the glucose 
feeding treatment, plasma insulin concentrations were significantly higher in the 
glucose treatment compared to the AMS treatment and placebo. Along with the 
higher concentrations of plasma insulin in the glucose treatment, a decrease in 
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plasma FFA concentration was observed. The observed blunting of FFA and 
glycerol concentration during exercise was similar to the studies done by Coyle (12) 
who indicated that ingesting glucose during exercise causes a rise in plasma insulin 
and decreases lipolysis. Because ingestion of AMS did not increase insulin above 
the level observed in the placebo treatment, no such inhibition of lipolysis was 
observed with ingestion of AMS. This finding, along with the observation of 
enhanced (compared to placebo) total carbohydrate oxidation and improved plasma 
glucose maintenance, suggests that AMS is acting more as a slowly digested CHO 
than as a resistant starch when ingested during exercise. 
It may seem logical that time to fatigue in the glucose trial should have been 
significantly greater than time to fatigue in the AMS trial, with respect to % glucose 
derived from exogenous CHO and exogenous CHO oxidized per minute using the 
13C extraction methods. In both cases the glucose treatments were significantly 
greater than the AMS treatments. This particular measurement of performance may 
not be sensitive enough to pick up the changes in CHO availability. Further studies 
need to be conducted to find a more sensitive endurance test that can detect these 
changes in CHO availability. 
If AMS is absorbed slower than glucose when ingested during exercise, it is 
possible that the ingestion protocol we used could result in incomplete digestion 
between successive feedings. Consequently, one might expect an accumulation of 
starch in the gut and associated feelings of lower abdominal fullness. In this study, 
we observed a higher rating of perceived fullness in the AMS treatments compared 
to the placebo and glucose treatments. However, none of the subjects indicated this 
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increased fullness caused them undue discomfort. In addition, ratings of perceived 
exertion were similar among all three treatments, suggesting that the increase 
fullness did not negatively influence their perception of effort. 
Time to fatigue in the AMS (158 min) and glucose (159 min) treatments were 
not different from each other, but both were prolonged in comparison with placebo 
(138 min). The improved endurance with glucose feeding is consistent with the 
earlier studies of Coggan and Coyle (8), which suggested that, improved ability to 
maintain plasma glucose and carbohydrate oxidation in the latter part of endurance 
exercise is responsible for the improved endurance. The finding that AMS improved 
endurance equally as well as glucose ingestion suggests that achieving 
hyperglycemia (as was the case with the glucose feeding) is not necessary to 
demonstrate the ergogenic effect of carbohydrate feedings during exercise. 
To confirm the absorption and oxidation of exogenous carbohydrate, we also 
measured the appearance of 13C in both plasma glucose and in expired C02. Based 
on these measurements after appropriate background subtraction (35), maximum 
exogenous CHO oxidation at the end of exercise was approximately 0.69 g/min in 
the glucose treatment compared to 0.21 g/min in the AMS treatment. This finding 
both confirms previous studies on glucose ingestion during exercise (7,8,9,15,26,30) 
and provides additional support to our observation of elevated CHO oxidation, 
compared to placebo, in the second hour of exercise. 
In conclusion, carbohydrate in the form of an acid-modified starch was 
digested, absorbed and metabolized when ingested during endurance exercise. 
This conclusion is indirectly supported by the improved maintenance of plasma 
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glucose and carbohydrate oxidation in the second hour of exercise leading to 
prolonged endurance equivalent to that seen with glucose ingestion. More direct 
measures of absorption and oxidation of the exogenous carbohydrate using 13C 
methodology confirms this conclusion. Because exogenous carbohydrate oxidation 
was lower when fed AMS than when fed glucose, future studies are needed to 
determine an optimal dosing protocol for acid-modified starch and to determine the 
percent digestibility in humans. 
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Table 4 Exogenous carbohydrate oxidation (g/min) after background subtraction 





















































4 5 6 7 8 9 
1.41 2.53 1.96 1.44 2.48 2.11 
1.34 1.77 1.91 1.39 2.33 2.03 
1.40 1.67 1.88 1.31 2.27 1.71 
0.71 1.82 2.26 1.34 2.20 1.72 
0.71 2.09 2.26 1.34 2.20 1.88 
1.35 2.36 2.22 1.79 2.72 2.20 
0.82 2.09 1.77 1.57 2.96 2.11 
0.91 2.13 1.78 1.61 2.47 2.12 
1.11 1.74 1.76 1.70 2.47 1.92 
1.00 1.74 1.77 1.70 2.55 1.85 
2.09 2.83 2.01 1.80 2.36 2.18 
2.03 2.40 1.94 1.79 2.24 2.31 
1.92 2.28 2.21 1.75 2.42 2.29 
2.05 2.51 2.10 1.78 2.26 2.17 


















Table 5 Plasma glucose concentration (mM) for subject and time period 































































4 5 6 7 8 9 
6.05 5.90 5.50 4.80 5.20 4.80 
5.80 5.20 6.00 4.70 5.10 4.70 
5.60 4.95 5.90 5.00 4.90 4.40 
5.05 4.95 5.20 4.90 4.30 4.40 
5.20 4.60 4.10 4.90 4.00 4.00 
5.20 4.20 4.10 4.90 3.40 3.50 
5.85 5.55 5.20 4.60 4.90 5.10 
5.35 5.30 5.20 4.60 5.00 5.00 
4.95 5.30 5.10 4.70 5.00 5.00 
5.30 5.25 5.40 5.00 4.90 4.80 
4.90 4.95 5.60 4.90 4.60 4.60 
4.80 4.95 5.00 4.90 4.00 4.60 
5.70 5.90 5.00 4.50 5.40 4.60 
6.56 6.00 5.50 4.90 5.80 5.70 
6.25 6.10 5.50 4.60 5.80 5.60 
5.90 5.95 5.30 4.60 5.40 5.20 
5.90 6.05 4.70 5.20 5.20 5.00 





















Table 6 Plasma insulin concentration (µIU/ml) for subject and time period for 
each experimental trial 
Trial Time Subject 
(min) 1 2 3 4 5 6 7 8 9 
Placebo 0 6.30 3.80 6.90 13.50 3.90 11.10 5.50 4.40 7.20 
30 1.20 3.00 4.20 1.80 1.70 7.70 4.50 2.60 11.20 
60 2.00 0.90 0.00 2.30 0.00 1.30 5.90 0.00 9.90 
90 0.00 2.20 2.10 0.00 0.60 0.00 4.40 0.00 7.00 
120 1.60 1.40 2.70 0.00 0.70 3.10 5.70 2.10 4.70 
EE 1.60 1.40 2.20 0.00 0.70 3.10 5.70 0.00 6.10 
AMS 0 8.80 9.50 2.70 8.50 5.90 1.40 7.20 6.60 9.00 
30 0.00 2.60 6.00 2.10 2.50 2.50 2.80 0.00 6.90 






























2.30 3.00 0.00 
3.00 3.60 0.00 
7.30 4.10 10.50 
26.10 16.80 3.20 
7.90 8.90 4.50 
7.90 8.80 3.30 
11.00 6.20 3.40 
11 6.70 1.40 
1.30 3.10 4.00 0.00 8.70 7.80 
1.30 1.00 4.00 0.80 8.70 6.20 
5.30 3.20 6.70 5.00 6.70 14.50 
6.90 4.30 7.20 5.80 5.10 11.50 
4.40 3.10 5.10 4.40 8.10 10.50 
2.30 3.00 6.40 0.00 9.40 12.40 
2.60 2.00 4.50 0.00 6.90 8.50 







EE= End of 
exercise 
57 
Plasma FF A concentration (mM) for subject and time 
period for each experimental trial 
Subject 
1 2 3 4 5 6 7 
0 0.34 0.26 0.26 0.47 0.72 0.64 0.69 
30 0.24 0.26 0.25 0.43 1.07 0.54 0.66 
60 0.31 0.46 0.39 0.42 0.98 0.60 0.80 
90 0.67 0.66 0.75 0.34 1.20 0.00 0.91 
120 1.04 0.80 1.42 0.88 1.15 0.77 1.12 
EE 1.04 0.80 1.10 0.88 1.63 0.00 1.12 
0 0.76 0.20 0.76 0.51 0.55 0.39 0.20 
30 0.45 0.17 0.54 0.65 0.41 0.45 0.35 
60 0.55 0.10 0.46 0.88 0.45 0.42 0.38 
90 0.68 0.22 1.09 1.07 0.61 0.61 0.70 
120 1.05 0.26 0.91 1.27 0.82 0.72 0.64 
EE 1.05 0.68 1.29 1.83 0.82 1.61 0.64 
0 0.54 0.00 0.39 0.57 0.28 0.51 0.81 
30 0.33 0.13 0.15 0.42 0.17 0.54 0.52 
60 0.18 0.12 0.19 0.39 0.70 0.41 0.49 
90 0.39 0.19 0.28 0.56 0.47 0.55 0.62 
120 0.61 0.26 0.40 0.85 0.52 0.89 0.72 
EE 0.81 0.47 0.64 1.29 0.65 0.89 0.72 
8 9 10 
0.35 0.49 0.00 
0.49 0.44 1.15 
0.50 0.51 1.13 
0.55 0.69 1.26 
0.55 0.83 1.85 
0.74 0.99 2.09 
0.23 0.59 0.00 
0.14 0.21 0.70 
0.12 0.39 0.86 
0.35 0.36 1.29 
0.42 0.57 1.81 
0.70 0.57 2.09 
0.65 0.57 0.00 
0.38 0.42 0.79 
0.26 0.30 0.46 
0.35 0.33 0.55 
0.35 0.35 1.18 
0.76 0.31 1.58 
58 
Table 8 Plasma glycerol concentration (mM) for subject and time period for 































































4 5 6 7 8 9 
0.24 0.38 0.05 0.35 0.10 0.22 
0.28 0.52 0.29 0.38 0.00 0.32 
0.45 1.08 0.40 0.47 0.28 0.42 
0.54 1.23 0.52 0.73 0.33 0.56 
0.75 1.78 0.73 0.10 0.38 0.62 
0.75 1.89 0.73 0.15 0.67 0.81 
0.25 0.25 0.00 0.10 0.10 0.39 
0.51 0.48 0.00 0.15 0.17 0.45 
0.69 0.63 0.13 0.25 0.28 0.66 
0.86 0.94 0.29 0.43 0.31 0.78 
1.33 1.26 0.39 0.47 0.38 0.72 
1.34 1.26 0.62 0.47 0.61 0.72 
0.18 0.22 0.00 0.26 0.17 0.37 
0.32 0.28 0.14 0.21 0.24 0.49 
0.55 0.44 0.09 0.23 0.20 0.49 
0.56 0.62 0.19 0.37 0.25 0.52 
0.56 0.84 0.38 0.40 0.27 0.58 





















Table g Plasma glucose (%) derived from exogenous carbohydrates for subject and 











































2 3 4 
0.00 0.00 0.00 
1.90 8.38 8.02 
11.15 10.52 22.90 
10.77 18.09 30.28 
16.73 21.57 29.13 
16.73 19.34 29.13 
0.00 0.00 0.00 
27.82 1.20 10.75 
44.53 8.97 2.54 
52.32 15.17 8.34 
53.98 16.28 0.10 
46.28 24.24 7.81 
0.00 0.00 0.00 
44.29 37.31 31.50 
67.84 85.15 41.08 
71.54 81.30 44.71 
63.83 72.56 46.89 
63.83 72.56 28.74 
Subject 
5 6 7 8 9 10 
0.00 0.00 0.00 0.00 0.00 0.00 
0.77 6.54 8.18 2.22 6.01 6.73 
0.00 8.38 10.88 1.37 11.45 5.86 
1.29 12.89 19.51 2.99 8.61 10.93 
7.05 18.61 26.98 7.19 9.18 16.52 
4.47 18.61 26.98 11.21 9.83 11.36 
0.00 0.00 0.00 0.00 0.00 0.00 
8.74 5.42 14.05 10.66 7.17 32.26 
16.09 16.60 24.35 20.26 21.74 52.92 
21.80 21.10 27.78 12.66 25.32 30.21 
30.54 15.85 26.14 21.31 33.44 33.50 
30.54 17.10 26.14 21.75 33.44 29.30 
0.00 0.00 0.00 0.00 0.00 0.00 
57.57 12.26 38.64 41.59 36.34 31.51 
64.07 42.38 51.72 58.49 57.24 45.42 
63.42 48.34 55.70 51.50 59.67 54.17 
55.90 45.62 58.09 50.93 64.55 53.60 
46.15 45.62 58.09 48.17 60.49 54.66 
60 
Table 10 Exogenous carbohydrate oxidation (g/min) after background 
subtraction for subject and time period for each experimental 
trial 































3 4 5 
0.00 0.00 0.00 
-0.18 -0.09 0.16 
-0.23 -0.09 0.15 
-0.15 -0.07 0.13 
-0.25 -0.10 0.11 
0.03 -0.05 0.11 
0.00 0.00 0.00 
0.67 0.12 0.50 
0.79 0.29 0.61 
0.77 0.35 0.74 
0.70 0.49 0.75 
0.82 0.55 0.71 
6 7 8 9 
0.00 0.01 -0.01 0.01 
0.01 0.13 0.23 -0.04 
0.18 0.22 0.20 0.08 
0.00 0.22 0.18 0.14 
0.14 0.33 0.20 0.20 
0.13 0.33 0.30 0.25 
0.00 0.03 -0.01 0.02 
0.15 0.41 0.17 0.25 
0.30 0.48 0.62 0.60 
0.44 0.60 0.63 0.72 
0.45 0.73 0.75 0.66 















Table 11 V02 (Umin) for subject and time period for each 
experimental trial 
Trial Time Subject 
(min) 1 2 3 4 5 6 7 
Placebo 0 0.33 0.38 0.25 0.39 0.42 0.40 0.39 
30 3.11 2.31 2.00 2.64 3.13 2.42 2.31 
60 3.28 2.68 2.10 2.74 3.13 2.44 2.31 
90 3.12 2.66 2.06 2.87 3.21 2.49 2.36 
120 3.27 2.72 2.13 2.74 3.21 2.48 2.41 
EE 3.27 2.72 2.07 2.74 3.27 2.48 2.41 
AMS 0 0.33 0.38 0.25 0.39 0.42 0.56 0.39 
30 3.21 2.29 2.15 2.64 3.09 2.46 2.31 
60 3.25 2.se 2.12 2.78 3.11 2.47 2.34 
90 3.27 2.59 2.11 2.78 3.17 2.48 2.35 
120 3.30 2.71 2.13 2.86 3.13 2.49 2.41 
EE 3.30 2.67 2.09 2.86 3.13 2.58 2.41 
Glucose 0 0.33 0.38 0.25 0.39 0.42 0.41 0.37 
30 3.41 2.61 2.16 2.59 2.95 2.56 2.31 
60 3.12 2.59 2.16 2.61 3.02 2.57 2.38 
90 3.28 2.41 2.12 2.63 2.99 2.59 2.40 
120 3.36 2.99 2.21 2.69 3.16 2.63 2.44 
EE 3.18 2.71 2.10 2.77 2.97 2.63 2.44 
EE= End of 
exercise 
8 9 10 
0.37 0.33 0.30 
2.31 2.50 2.37 
2.38 2.54 2.39 
2.40 2.58 2.31 
2.44 2.60 2.55 
2.44 2.65 2.55 
0.46 0.30 0.36 
2.74 2.47 2.36 
2.70 2.49 2.39 
2.85 2.54 2.40 
2.85 2.59 2.52 
2.86 2.62 2.55 
0.46 0.33 0.43 
2.65 2.51 2.39 
2.69 2.57 2.35 
2.76 2.61 2.49 
2.80 2.54 2.53 







EE= End of 
exercise 
62 
Respiratory exchange ration (VC02N02) for subject and time 
period for each experimental trial 
Subject 
1 2 3 4 5 6 7 8 9 
0 0.92 0.84 0.75 0.78 0.81 0.78 0.77 0.85 0.78 
30 0.91 0.90 0.92 0.82 0.88 0.88 0.84 0.89 0.89 
60 0.86 0.97 0.88 0.81 0.83 0.88 0.84 0.88 0.88 
90 0.81 0.85 0.87 0.81 0.82 0.87 0.83 0.88 0.85 
120 0.76 0.84 0.86 0.76 0.83 0.90 0.83 0.87 0.85 
EE 0.76 0.84 0.86 0.76 0.84 0.90 0.83 0.87 0.86 
0 0.92 0.84 0.75 0.78 0.81 0.81 0.81 0.84 0.82 
30 0.87 0.93 0.92 0.82 0.87 0.90 0.87 0.92 0.90 
60 0.85 0.92 0.90 0.77 0.85 0.86 0.85 0.94 0.89 
90 0.85 0.92 0.87 0.78 0.85 0.86 0.85 0.89 0.89 
120 0.86 0.91 0.88 0.79 0.83 0.86 0.86 0.89 0.87 
EE 0.86 0.87 0.86 0.78 0.83 0.85 0.86 0.90 0.86 
0 0.92 0.84 0.75 0.78 0.81 0.81 0.77 1.00 0.79 
30 0.88 0.90 0.90 0.88 0.91 0.88 0.87 0.90 0.89 
60 0.90 0.89 0.90 0.87 0.88 0.87 0.87 0.89 0.90 
90 0.89 0.96 0.91 0.86 0.87 0.89 0.86 0.90 0.90 
120 0.89 0.86 0.87 0.87 0.88 0.88 0.86 0.88 0.89 





















Table 13 Time (min) to fatigue for each subject and 
experimental trial 
Trial Time Subject 
(min) 1 2 3 4 5 6 7 8 9 10 
Placebo 129.0 116.0 169.0 117.0 133.0 150.0 108.0 181.0 137.0 142.0 
AMS 
Glucose 
EE= End of 
exercise 
148.0 153.0 198.0 130.0 122.0 198.0 106.0 210.0 151.0 162.0 
136.0 138.0 155.0 211.0 150.0 120.0 120.0 212.0 150.0 199.0 
64 
Table 14 Rating of perceived exertion (Borg Scale 6-20) for subject and 
time period for each experimental trial 






























































3 4 5 6 
10.0 12.0 13.0 9.0 
10.0 12.0 12.0 11.0 
11.0 13.0 13.0 12.0 
11.0 13.0 14.0 13.0 
11.0 15.0 14.0 13.0 
12.0 16.0 15.0 13.0 
13.0 16.0 16.0 15.0 
15.0 16.0 17.0 16.0 
17.0 16.0 17.0 19.0 
10.0 13.0 12.0 9.0 
12.0 13.0 13.0 11.0 
12.0 14.0 13.0 12.0 
12.0 14.0 13.0 13.0 
12.0 13.0 15.0 13.0 
11.0 14.0 15.0 14.0 
12.0 15.0 17.0 15.0 
12.0 16.0 16.0 16.0 
18.0 16.0 16.0 19.0 
10.0 13.0 12.0 10.0 
10.0 14.0 12.0 11.0 
10.0 13.0 11.0 13.0 
11.0 14.0 12.0 14.0 
11.0 14.0 13.0 15.0 
12.0 14.0 13.0 15.0 
13.0 15.0 15.0 17.0 
13.0 15.0 15.0 19.0 
16.0 16.0 15.0 19.0 
7 8 9 
13.0 11.0 9.0 
13.0 12.0 12.0 
13.0 12.0 12.0 
16.0 12.0 13.0 
17.0 13.0 14.0 
19.0 13.0 14.0 
19.0 14.0 15.0 
19.0 15.0 16.0 
19.0 19.0 17.0 
12.0 11.0 11.0 
13.0 11.0 12.0 
14.0 11.0 12.0 
14.0 12.0 13.0 
15.0 12.0 13.0 
17.0 12.0 15.0 
17.0 13.0 15.0 
17.0 14.0 16.0 
17.0 16.0 16.0 
12.0 11.0 13.0 
14.0 12.0 13.0 
15.0 12.0 13.0 
15.0 12.0 14.0 
16.0 13.0 14.0 
17.0 13.0 15.0 
19.0 14.0 15.0 
19.0 15.0 15.0 






























Table 15 Fullness index (1-10, 10 =full} for subject 




























































































4 5 6 7 
1.0 1.0 1.0 1.0 
1.0 2.0 3.0 1.0 
1.0 2.0 2.0 1.0 
1.0 2.0 3.0 2.0 
1.0 2.0 3.0 1.0 
1.0 2.0 3.0 0.0 
1.0 2.0 5.0 0.0 
1.0 2.0 5.0 0.0 
1.0 2.0 6.0 0.0 
1.0 1.0 0.0 3.0 
1.0 1.0 2.0 4.0 
1.0 1.0 3.0 6.0 
1.0 1.0 3.0 6.0 
1.0 2.0 4.0 7.0 
2.0 1.0 4.0 7.0 
2.0 2.0 4.0 8.0 
2.0 1.0 7.0 8.0 
2.0 1.0 9.0 8.0 
1.0 1.0 1.0 1.0 
1.0 2.0 1.0 2.0 
1.0 1.0 1.0 2.0 
1.0 1.0 1.0 3.0 
1.0 1.0 1.0 3.0 
1.0 1.0 1.0 3.0 
1.0 1.0 0.0 3.0 
1.0 1.0 0.0 3.0 
o.o· 1.0 0.0 3.0 
8 9 10 
2.0 5.0 3.0 
1.0 5.0 3.0 
1.0 5.0 3.0 
1.0 5.0 3.0 
1.0 3.0 3.0 
0.0 2.0 3.0 
0.0 1.0 3.0 
0.0 0.0 3.0 
0.0 0.0 3.0 
1.0 6.0 2.0 
3.0 5.0 3.0 
6.0 5.0 3.0 
7.0 4.0 3.0 
6.0 3.0 3.0 
3.0 2.0 3.0 
5.0 2.0 5.0 
3.0 1.0 5.0 
4.0 1.0 5.0 
1.0 3.0 1.0 
1.0 3.0 1.0 
1.0 3.0 1.0 
1.0 2.0 1.0 
1.0 1.0 2.0 
1.0 1.0 2.0 
2.0 1.0 2.0 
2.0 1.0 2.0 
2.0 1.0 2.0 
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Project Title: Exercise Q-lycemic responses to ingestion of acid/alcohol modified starches 
Principal Investigator: Rick L. Sharp 
250 Forker Bldg 
294-8650 
CONSENT FORM 
Liquid nutritional supplements generally contain relatively large amounts of 
simple sugars such as glucose and sucrose. These foods are said to have a high 
glycemic index (i.e., they cause a large increase in the blood glucose concentration) 
and long term use of high glycemic foods poses certain health risks such as 
elevated blood lipids. In addition, ingestion of high glycemic sugars in sports drinks 
in the hour before exercise has been shown to impair endurance performance. We 
have developed com starches that are water soluble when modified by pre-soaking 
in an alcohol and acid mixture and have a low glycemic index. This property allows 
these starches to provide a "timed-release" of carbohydrate that may enhance 
endurance performance. This project is designed to test this hypothesis. 
On your first visit to the laboratory, you will be tested for your maximal aerobic 
capacity. This test involves about 20 minutes of cycling on a stationary bike. After a 
4 minute warmup period, you will cycle at a very easy workload for 3 minutes and 
workload will be increased by 40 watts every 3 minutes until you feel that you can no 
longer maintain the pedal cadence at 70 rpm. During this test you will breathe 
through a breathing valve that will direct your expired air into the gas analyzers for 
measurement of oxygen uptake. From the results of this test, we will determine the 
workload for you to use when you perform the 2 hour endurance trials. 
Within about one week after your maximal aerobic capacity test, you will 
perform the first of three two-hour endurance cycling trials: 1) 30 minutes after 
ingesting 75 g glucose, 2) 30 minutes after ingesting 75 g of the modified com 
starch, and 3) 30 minutes after ingesting a placebo. The identity of each beverage 
will be disguised so that neither you nor we will know which beverage you have 
consumed until the end of the study. The exercise intensity for these endurance 
rides will be set at 70% of your maximal aerobic capacity. This intensity is fairly 
typical of the intensities most cyclists use during their harder endurance training 
rides. These treatments will be scheduled about one week apart and will be 
conducted in the Exercise Physiology Laboratory (283 Forker Bldg). During 
each of the experimental trials, a small flexible catheter will be placed in a forearm 
vein to take samples of blood before ingestion of the beverage and every 30 minutes 
thereafter until the end of the endurance ride. Catheter placement and blood 
sampling will be performed by trained personnel. Each blood sample will later 
be analyzed for glucose, free fatty acid, and insulin concentrations to determine the 
metabolic responses to each beverage. Also during the endurance rides, you will 
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breathe through the breathing valve for 5 minutes at the end of each 30 minute 
period for the measurement of oxygen uptake. 
At any time during the study you may withdraw your consent to participate 
without prejudice towards you. Such withdrawal may be for any reason you choose. 
Constant monitoring of all experiments will be performed by knowledgeable and 
CPR trained individuals in an attempt to prevent any complications. Emergency first 
aid supplies and equipment will be immediately available. 
Emergency treatment of any injuries that may occur as a direct result of 
participation in this research will be treated at the Iowa State University Student 
Health Services, Student Services Building, and/or referred to Mary Greeley Medical 
Center or another physician. Compensation for treatment of any injuries that may 
occur as a direct result of participation in this research may or may not be paid by 
Iowa State University depending on the Iowa Tort ClaimsAct. Claims for 
compensation will be handled by the Iowa State University Vice President for 
Business and Finance. 
Your questions on any aspect of this research project are welcomed. At the 
conclusion of the study you will be informed of the results of the study and the 
conclusions drawn. Your results will be kept absolutely confidential and should your 
data be used in publication of the results, your name or any identifying 
characteristics will not be reported. 
* * * * 
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MEDICAL HISTORY QUESTIONNAIRE 
Please respond to the following items as accurately as possible. This information will be 
used by the investigator to ensure a safe exercise environment and to determine if there are 
any contraindications to exercise or participation in this study. All information will remain 
confidential unless further professional consultation is warranted. 
A) Personal Information 
Name ___________ Age ____ Tel.# _______ _ 
Height. ______ Weight..__ _____ Male or Female (circle) 
B) Medical Information 
1. How would you describe your recent general health? 
Excellent Good Fair Poor ----
2. Place an X in those boxes which describe symptoms or disorders which you have 
been diagnosed to have. If possible, also indicate the date of the diagnosis. 
__ high blood pressure arthritis chest pain 
__ irregular heart beat epilepsy heart attack 
__ heart murmur anemia migraine 
asthma back trouble headaches ----hay fever or other allergies dizziness/ diabetes 
__ other fainting spells 
3. Describe any surgery that you have had within the last two years: ____ _ 
4. Have you ever sustained an injury or experienced any type of chronic pain which 
has been diagnosed as due to physical activity or sports participation? 
Yes No ---If yes, please describe ___________________ _ 
How long ago? __________________________ _ 
5. Do you smoke cigarettes? __ Yes __ No 
6. Are you presently taking any of the following medications? 
__ drugs to control blood pressure drugs for asthma 
-- drugs to regulate heart rate drugs for diabetes --drugs for allergies thyroid hormone 
__ cortisone prednisone 
Indicate the name(s) of those drugs ____________________________ _ 
Also note the dosage and frequency of use __________________ _ 
7. How long has it been since your last physical examination? 
__ less than 1 year 
__ more than 3 years 
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__ 1-2years __ 2-3years 
8. Have any of the above symptoms, disorders or injuries limited your physical 
activity in the past? ____________________ _ 
In what way? _______________________ _ 
C) Family Medical History 
1. Have any of your blood relatives been diagnosed as having any of the following 
symptoms/disorders? (Include grandparent, parents, brothers, sisters) 
__ heart attack, under age 50 asthma or hay fever 
__ stroke, under age 50 congenital heart disease 
__ high blood pressure heart surgery 
__ hyperlipidemia (high cholesterol) diabetes 
__ obesity 
__ other -----------
D) Exercise Information 
1. List and give the date of any supervised exercise or sports program that you have 
participated in recently __________________ _ 
2. Are you currently participating in a regular program of physical activity? 
Yes No. --If yes, how often do you exercise per week (on average)? 
__ 1-2 days/wk 5-6 days/wk 
__ 3-4 days/wk every day 
For how long do you exercise each day? 
__ < 30 min/day 30-60 min/day 
__ 60-90 min/day 90-120 min/day 
__ > 120 min/day 
What types of activities are regularly included in your program? 
__ jogging calisthenics 
__ cycling swimming 
__ weight lifting aerobic dance 
__ recreational sports (basketball, racquetball, volleyball, tennis, etc) 
__ other ________________ _ 
How long have you been in your present program? 
__ less than 1 month 6 months to 1 year 
__ 1-3 months more than 1 year 
__ 3-6 months 
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3. How would you categorize your current physical fitness level? 
__ superior good average below average 
__ poor 
4. Is there any reason why you think your activity should be limited in this research 
pr~ect? ____________________ ~ 
I attest that all of the above information is accurate to the best of my knowledge 
Signed Date ________ ......... _ 
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Your Pre-Trial Low-Corn Diet 
For this experiment, we will be measuring the amount of the stable isotope 13C that 
appears in your blood and your expired air after ingesting the four kinds of 
carbohydrate to be used in this study. Three of the four carbohydrates you will 
ingest have fairly high contents of 13C because the carbohydrates are derived from 
corn, a plant that makes an abundance of 13C. The problem we face in using this 
method to measure your digestion of the carbohydrate is that lots of the foods you 
eat on a daily basis contain corn or corn products and if your diet in the days 
immediately before your trial has lots of corn products in it, the "background" amount 
of 13C in your blood and expired air might be so high that we have a hard time 
detecting the effect of the experimental feeding. 
Consequently, it is important that you try your best to minimize the amount of corn 
and corn products in your diet FOR THREE DAYS BEFORE 
EACH OF YOUR TRIALS. To help us check the amount of com and 
corn products in your diet, we will ask you to keep a written record of all the foods 
and beverages you consume during the 3 days before your first trial. Then on each 
of your subsequent trials, we'll ask that you reproduce that same diet as closely as 
possible. 
Remember.... ~ Try to choose foods and beverages with as little corn or corn 
products as possible for 3 days before your first trial, and 
~ Pick foods and beverages in that first 3 day period that will be easy 
for you to duplicate for your subsequent trials. 
Here are some Foods and/or Ingredients that contain or 












Corn chips/potato chips 
Corn flour/starch 
Corn oil 
Corn syrup solids 
Dextrose 
Sweetened beverages (soda pop) 






Meats (especially beefsteak) 
Margarine 
Sugar made from cane 
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Most breakfast cereals 
"Exotic" fruits 
Some acceptable alternatives: 
Rice Chex 
Unsweetened fruit juice 
Fresh fruits & veges 
Whole wheat bread 











Tea (unsweetened or Equal) 
